Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00969124 · ClinicalTrials.gov registry record · NA

Impact of Experience on Results With the Third Eye Retroscope

A NA study of Colorectal Neoplasms, sponsored by Avantis Medical Systems.

Completed
Registry status
NA
Development phase
328
Enrollment target
9
Study locations

NCT00969124 is a NA study of Colorectal Neoplasms that has completed, run by Avantis Medical Systems. The registered enrollment target is 328 participants, below the 570-participant average among 54 other Colorectal Neoplasms trials with a reported enrollment target (42% lower). The trial reports 9 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00969124, a NA study of Colorectal Neoplasms, has completed, sponsored by Avantis Medical Systems.

COMPLETED
Registry status
NA
Development phase
328 participants
Enrollment target
9
Study locations

Study Summary

The Third Eye Retroscope is a device that can be used with a colonoscope to improve the ability of a physician to see areas of the colon that may be hidden from the view of the colonoscope. Previous studies have shown that physicians are able to detect additional polyps when they use the device along with the colonoscope. The purpose of this study is to determine whether physicians can detect greater numbers of additional polyps as they gain in experience with the device.

Conditions Studied

Interventions

  • DEVICE Third Eye Retroscope

Study Locations (9)

Texas

  • Parkland Hospital - Dallas
  • Baylor University Medical Center - Dallas
  • S.W. Fort Worth Endoscopy Center - Fort Worth
  • North Hills Hospital - North Richland Hills

Illinois

  • University of Chicago - Chicago
  • NorthShore University HealthSystem - Evanston

Florida

  • Florida Hospital - Celebration

Massachusetts

  • University of Massachusetts - Worcester

Minnesota

  • Hennepin County Medical Center - Minneapolis

Trial Details

FieldValue
Enrollment Target 328 participants
Start Date 2009-01
Est. Completion 2009-10
Phase NA

Sponsor

Avantis Medical Systems

2 total trials

What the Registry Record Tells You About NCT00969124

The ClinicalTrials.gov registry entry for NCT00969124 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 328 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 570-participant average among 54 other Colorectal Neoplasms trials with a reported enrollment target (42% lower). The listed sponsor is Avantis Medical Systems, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colorectal Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Third Eye Retroscope is the first listed.

NCT00969124 reports 9 study locations spanning 5 distinct geographic areas - top geographies include Texas, Illinois, Florida.

Frequently Asked Questions

What is clinical trial NCT00969124 about?

NCT00969124 is a clinical study titled "Impact of Experience on Results With the Third Eye Retroscope". The Third Eye Retroscope is a device that can be used with a colonoscope to improve the ability of a physician to see areas of the colon that may be hidden from the view of the colonoscope. Previous studies have shown that physicians are able to detect additional polyps when they use the device alo...

What is the current status of trial NCT00969124?

This trial is currently completed. It is a NA study. The enrollment target is 328 participants. The study started on 2009-01. Estimated completion is 2009-10.

What conditions does trial NCT00969124 study?

This clinical trial studies the following conditions: Colorectal Neoplasms.

What interventions are being tested in trial NCT00969124?

The interventions under investigation include: Third Eye Retroscope (DEVICE).

Who is sponsoring clinical trial NCT00969124?

This trial is sponsored by Avantis Medical Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00969124 being conducted?

This trial has 9 study locations across Florida, Illinois, Massachusetts, Minnesota, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.